240
Views
1
CrossRef citations to date
0
Altmetric
Review

3D printing of bioactive materials for drug delivery applications

, , , , , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 1061-1080 | Received 19 May 2022, Accepted 10 Aug 2022, Published online: 22 Aug 2022

References

  • Vahabi H, Laoutid F, Mehrpouya M, et al. Flame retardant polymer materials: an update and the future for 3D printing developments. Mater Sci Eng R Rep. 2021;144:100604.
  • Agrawaal H, Thompson JE, Additive manufacturing (3D printing) for analytical chemistry. Talanta Open. 2021;3:100036.
  • Wang C, Huang W, Zhou Y, et al. 3D printing of bone tissue engineering scaffolds. Bioact Mater. 2020;5(1):82–91.
  • Barry RA III, Shepherd RF, Hanson JN, et al. Direct‐write assembly of 3D hydrogel scaffolds for guided cell growth. Adv Mater. 2009;21(23):2407–2410.
  • Kuang X, Roach DJ, Wu J, et al. Advances in 4D printing: materials and applications. Adv Funct Mater. 2019;29(2):1805290.
  • Norman J, Madurawe RD, Moore CM, et al. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Reviews. 2017;108:39–50.
  • Liaw C-Y, Guvendiren M. Current and emerging applications of 3D printing in medicine. Biofabrication. 2017;9(2):024102.
  • Yoo J, Bradbury TJ, Iskra J, et al. Three-dimensional printing system and equipment assembly. Google Patents; 2016.
  • Zarrintaj P, Saeb MR, Ramakrishna S, et al. Biomaterials selection for neuroprosthetics. Curr Opin Biomed. 2018;6:99–109.
  • Conner BP, Manogharan GP, Martof AN, et al. Making sense of 3-D printing: creating a map of additive manufacturing products and services. Addit Manuf. 2014;1:64–76.
  • Attaran M. The rise of 3-D printing: the advantages of additive manufacturing over traditional manufacturing. Bus Horiz. 2017;60(5):677–688.
  • Chia HN, Wu BM. Recent advances in 3D printing of biomaterials. J Biol Eng. 2015;9(1):1–14.
  • Hwa LC, Rajoo S, Noor AM, et al. Recent advances in 3D printing of porous ceramics: a review. Curr Opin Solid State Mater Sci. 2017;21(6):323–347.
  • Mu X, Bertron T, Dunn C, et al. Porous polymeric materials by 3D printing of photocurable resin. Mater Horiz. 2017;4(3):442–449.
  • Lacey SD, Kirsch DJ, Li Y, et al. Extrusion‐based 3D printing of hierarchically porous advanced battery electrodes. Adv Mater. 2018;30(12):1705651.
  • Lv J, Gong Z, He Z, et al. 3D printing of a mechanically durable superhydrophobic porous membrane for oil–water separation. J Mater Chem A. 2017;5(24):12435–12444.
  • Ligon SC, Liska R, Stampfl J, et al. Polymers for 3D printing and customized additive manufacturing. Chem Rev. 2017;117(15):10212–10290.
  • Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 2016;499(1–2):376–394.
  • Perrie Y, Rades T. FASTtrack pharmaceutics: drug delivery and targeting. Pharmaceutical Press; 2012.
  • Wei C, Solanki NG, Vasoya JM, et al. Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release. J Pharm Sci. 2020;109(4):1558–1572.
  • Gültekin HE, Tort S, Acartürk F. Fabrication of three dimensional printed tablets in flexible doses: a comprehensive study from design to evaluation. J Drug Deliv Sci Technol. 2022 Aug 01;74:103538.
  • Liu F, Lizio R, Meier C, et al. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine. J Control Release. 2009;133(2):119–124.
  • Okwuosa TC, Pereira BC, Arafat B, et al. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 2017;34(2):427–437.
  • Cheng Y, Qin H, Acevedo NC, et al. 3D printing of extended-release tablets of theophylline using hydroxypropyl methylcellulose (HPMC) hydrogels. Int J Pharm. 2020;591:119983.
  • Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.
  • Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed. 2014;53(46):12320–12364.
  • Zhao X, Wei W, Niu R, et al. 3D printed intragastric floating and sustained-release tablets with air chambers. J Pharm Sci. 2022;111(1):116–123.
  • Jeong HM, Weon KY, Shin BS, et al. 3D-Printed gastroretentive sustained release drug delivery system by applying design of experiment approach. Molecules. 2020; 25(10): 2330.
  • Algahtani MS, Mohammed AA, Ahmad J, et al. Development of a 3D printed coating shell to control the drug release of encapsulated immediate-release tablets. Polymers. 2020;12(6):1395.
  • Stadtmauer L, Waud K. Progesterone vaginal ring for luteal support. J Obstet Gynecol India. 2015;65(1):5–10.
  • Morita R, Honda R, Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS): I. Design of SCRS and its release controlling factor. J Control Release. 2000;63(3):297–304.
  • Tang X, Alavi S. Recent advances in starch, polyvinyl alcohol based polymer blends, nanocomposites and their biodegradability. Carbohydr Polym. 2011;85(1):7–16.
  • Roper DM, Kwon K-A, Best SM, et al. The 3D Printing of freestanding PLLA thin layers and improving first layer consistency through the introduction of sacrificial PVA. Appl Sci. 2021;11(14):6320.
  • Goyanes A, Martinez PR, Buanz A, et al. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494(2):657–663.
  • Martini LG, Crowley PJ. Controlling drug release in oral product development programs: an industrial perspective. Springer: Controlled release in oral drug delivery; 2011. p. 49–69.
  • Goyanes A, Wang J, Buanz A, et al. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm. 2015;12(11):4077–4084.
  • Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS Pharm Sci Tech. 2016;17(1):20–42.
  • Goyanes A, Kobayashi M, Martínez-Pacheco R, et al. Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm. 2016;514(1):290–295.
  • Satinderkakar RS. Gastroretentive drug delivery systems: a review. Afr J Pharm Pharmacol. 2015;9(12):405–417.
  • Charoenying T, Patrojanasophon P, Ngawhirunpat T, et al. Fabrication of floating capsule-in-3D-printed devices as gastro-retentive delivery systems of amoxicillin. J Drug Deliv Sci Technol. 2020;55:101393.
  • Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 2015;68:11–17.
  • Bettencourt A, Almeida AJ. Poly (Methyl Methacrylate)(PMMA): drug delivery applications. Encycl Biomed Polym Polym Biomater. 2015:6511–6525.
  • Champeau M, Thomassin JM, Tassaing T, et al. Drug loading of polymer implants by supercritical CO2 assisted impregnation: a review. J Control Release. 2015;209:248–259.
  • Ngo TT, Hoffman L, Hoople GD, et al. Surface morphology and drug loading characterization of 3D-printed methacrylate-based polymer facilitated by supercritical carbon dioxide. J Supercrit Fluids. 2020;160:104786.
  • Brighton C. Styrene polymers and food packaging. Food Chem. 1982;8(2):97–107.
  • Aldousiri B, Shalwan A, Chin C. A review on tribological behaviour of polymeric composites and future reinforcements. Adv Mater Sci Eng. 2013;2013:1–8.
  • Li Y, Shimizu H. Improvement in toughness of poly (l-lactide)(PLLA) through reactive blending with acrylonitrile–butadiene–styrene copolymer (ABS): morphology and properties. Eur Polym J. 2009;45(3):738–746.
  • Di Pasquale G, Di Iorio G, Capaccioli T, et al. Gas chromatographic head-space determination of residual acrylonitrile in acrylonitrile-butadiene-styrene resins and migration into a simulated fatty foodstuffs liquid. J Chromatogr A. 1978;160(1):133–140.
  • Chan E, Lee HS, Hue SS. Population pharmacokinetics of carbamazepine in Singapore epileptic patients. Br J Clin Pharmacol. 2001;51(6):567–576.
  • Kong ST, Lim SH, Chan E, et al. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication. J Clin Pharmacol. 2014;54(2):225–233.
  • Miller A, Krauss G, Hamzeh F. Improved CNS tolerability following conversion from immediate‐to extended‐release carbamazepine. Acta Neurol Scand. 2004;109(6):374–377.
  • Lim SH, Chia SMY, Kang L, et al. Three-dimensional printing of carbamazepine sustained-release scaffold. J Pharm Sci. 2016;105(7):2155–2163.
  • Wasilewska K, Winnicka K. Ethylcellulose–A pharmaceutical excipient with multidirectional application in drug dosage forms development. Materials. 2019;12(20):3386.
  • Trofimiuk M, Wasilewska K, Winnicka K. How to modify drug release in paediatric dosage forms? Novel technologies and modern approaches with regard to children’s population. Int J Mol Sci. 2019;20(13):3200.
  • Kou W, Cai C, Xu S, et al. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Int J Pharm. 2011;409(1–2):75–80.
  • Powell G, Saunders M, Rigby A, et al. Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy. Cochrane Database Syst Rev. 2010;20(1):CD007124.
  • Borujeni SH, Mirdamadian SZ, Varshosaz J, et al. Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero order sustained release profile. Cellulose. 2020;27(3):1573–1589.
  • Cheng K, Zhu J, Song X, et al. Studies of hydroxypropyl methylcellulose donut-shaped tablets. Drug Dev Ind Pharm. 1999;25(9):1067–1071.
  • Mishra DS, Yalkowsky SH. A flat circular hole device for zero-order release of drugs: characterization of the moving dissolution boundary. Pharm Res. 1990;7(11):1195–1197.
  • Bayomi MA. Geometric approach for zero-order release of drugs dispersed in an inert matrix. Pharm Res. 1994;11(6):914–916.
  • Narasimhan B, Langer R. Zero-order release of micro-and macromolecules from polymeric devices: the role of the burst effect. J Control Release. 1997;47(1):13–20.
  • Danckwerts M, Watt JVD, Moodley I. Zero-order release of theophylline from a core-in-cup tablet in sequenced simulated gastric and intestinal fluid. Drug Dev Ind Pharm. 1998;24(2):163–167.
  • Lu M, Novel excipients and materials used in FDM 3D Printing of pharmaceutical dosage forms. 3D and 4D Print Biomed Appl: Process Eng Addit Manuf. 2019.
  • Fulbandhe V, Jobanputra C, Wadher K, et al. Evaluation of release retarding property of gum damar and gum copal in combination with hydroxypropyl methylcellulose. Indian J Pharm Sci. 2012;74(3):189.
  • Deshmukh K, Ahamed MB, Deshmukh R, et al. Biopolymer composites with high dielectric performance: interface engineering. Biopolymer composites electron: Elsevier 2017;27–128
  • Khaled SA, Burley JC, Alexander MR, et al. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm. 2014; 461(1–2): 105–111.
  • Repka MA, Gerding TG, Repka SL, et al. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev Ind Pharm. 1999;25(5):625–633.
  • Repka MA, McGinity JW. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J Control Release. 2001;70(3):341–351.
  • Arafat B, Wojsz M, Isreb A, et al. Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci. 2018;118:191–199.
  • Scoutaris N, Ross SA, Douroumis D. 3D printed “Starmix” drug loaded dosage forms for paediatric applications. Pharm Res. 2018;35(2):34.
  • Gryczke A, Schminke S, Maniruzzaman M, et al. Development and evaluation of orally disintegrating tablets (ODTs) containing ibuprofen granules prepared by hot melt extrusion. Colloids Surf B. 2011;86(2):275–284.
  • Thakral S, Thakral NK, Majumdar DK. Eudragit®: a technology evaluation. Expert Opin Drug Deliv. 2013;10(1):131–149.
  • Azad MA, Olawuni D, Kimbell G, et al. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Pharmaceutics. 2020;12(2):124.
  • Arafat B, Qinna N, Cieszynska M, et al. Tailored on demand anti-coagulant dosing: an in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms. Eur J Pharm Biopharm. 2018;128:282–289.
  • Hill S, Varker AS, Karlage K, et al. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009;15(3):253–261.
  • Polli JE, Kim S, Martin BR. Weight uniformity of split tablets required by a veterans affairs policy. J Manag Care Pharm. 2003;9(5):401–407.
  • Martin KS, McPherson TB, Fontane PE, et al. Independent community pharmacists’ perspectives on compounding in contemporary pharmacy education. Am J Pharm Educ. 2009;73(3):54.
  • Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015;96:380–387.
  • Clark EA, Alexander MR, Irvine DJ, et al. 3D printing of tablets using inkjet with UV photoinitiation. Int J Pharm. 2017;529(1–2):523–530.
  • Kadry H, Wadnap S, Xu C, et al. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur J Pharm Sci. 2019;135:60–67.
  • Nikkhah M, Akbari M, Paul A, et al. Gelatin‐based biomaterials for tissue engineering and stem cell bioengineering. Biomater Nat Adv Devices Ther. 2016.
  • Hernández-Muñoz P, Villalobos R, Chiralt A. Effect of cross-linking using aldehydes on properties of glutenin-rich films. Food Hydrocoll. 2004;18(3):403–411.
  • Santoro M, Tatara AM, Mikos AG. Gelatin carriers for drug and cell delivery in tissue engineering. J Control Release. 2014 Sep 28;190:210–218.
  • Etxabide A, Long J, Guerrero P, et al. 3D printed lactose-crosslinked gelatin scaffolds as a drug delivery system for dexamethasone. Eur Polym J. 2019;114:90–97.
  • Zhou L, Ramezani H, Sun M, et al. 3D printing of high-strength chitosan hydrogel scaffolds without any organic solvents. Biomater Sci. 2020;8(18):5020–5028.
  • Hafezi F, Scoutaris N, Douroumis D, et al. 3D printed chitosan dressing crosslinked with genipin for potential healing of chronic wounds. Int J Pharm. 2019;560:406–415.
  • Bonfield W, Hastings GW, Tanner K. Bioceramics: Proceedings of the 4th International Symposium on Ceramics in Medicine; September; London, UK: Elsevier. 1991.
  • Vorndran E, Klammert U, Ewald A, et al. Simultaneous immobilization of bioactives during 3D powder printing of bioceramic drug‐release matrices. Adv Funct Mater. 2010;20(10):1585–1591.
  • Gbureck U, Vorndran E, Barralet JE. Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater. 2008;4(5):1480–1486.
  • Inzana JA, Trombetta RP, Schwarz EM, et al. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur Cells Mater. 2015;30:232.
  • Rezwan K, Chen Q, Blaker JJ, et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27(18):3413–3431.
  • Brady R, Leid J, Costerton J, et al. Osteomyelitis: clinical overview and mechanisms of infection persistence. Clin Microbiol Newsl. 2006;28(9):65–72.
  • Martínez-Vázquez F, Cabañas M, Paris J, et al. Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration. Acta Biomater. 2015;15:200–209.
  • Fernandes HR, Gaddam A, Rebelo A, et al. Bioactive glasses and glass-ceramics for healthcare applications in bone regeneration and tissue engineering. Materials. 2018;11(12):2530.
  • Baino F, Fiume E. 3D printing of hierarchical scaffolds based on mesoporous bioactive glasses (MBGS)-fundamentals and applications. Materials. 2020;13(7):1688.
  • Migneco C, Fiume E, Verné E, et al. A guided walk through the world of Mesoporous Bioactive Glasses (MBGs): fundamentals, processing, and applications. Nanomaterials. 2020;10(12):2571.
  • Zhao S, Zhang J, Zhu M, et al. Three-dimensional printed strontium-containing mesoporous bioactive glass scaffolds for repairing rat critical-sized calvarial defects. Acta Biomater. 2015;12:270–280.
  • Goyanes A, Buanz AB, Hatton GB, et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2015;89:157–162.
  • Homaee Borujeni S, Mirdamadian SZ, Varshosaz J, et al. Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero order sustained release profile. Cellulose. 2020;27(3):1573–1589.
  • Olgac S, Yilmaz Usta D, Incecayir T. Comparison of tablet splitting techniques for dosing accuracy of nebivolol tablets: hand splitting versus tablet cutter and knife. Saudi Pharm J. 2021;29(12):1486–1491.
  • Mohammed AA, Algahtani MS, Ahmad MZ, et al. 3D Printing in medicine: technology overview and drug delivery applications. Ann 3D Print Med. 2021; 4: 100037.
  • Samiei N. Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: a mini review. Beni-Suef Univ J Basic Appl Sci. 2020;9(1):12.
  • Zhu X, Li H, Huang L, et al. 3D printing promotes the development of drugs. Biomed Pharmacother. 2020;131:110644.
  • Ali A, Ahmad U, Akhtar J. 3D Printing in pharmaceutical sector: an overview. 2020.
  • Mahmood MA. 3D printing in drug delivery and biomedical applications: a state-of-the-art review. Compounds. 2021;1(3):94–115.
  • Wang Z, Han X, Chen R, et al. Innovative color jet 3D printing of levetiracetam personalized paediatric preparations. Asian J Pharm Sci. 2021;16(3):374–386.
  • Pardeike J, Strohmeier DM, Schrödl N, et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm. 2011 Nov 25;420(1):93–100.
  • Martinez PR, Goyanes A, Basit AW, et al. Fabrication of drug-loaded hydrogels with stereolithographic 3D printing. Int J Pharm. 2017;532(1):313–317.
  • Buanz A, Saunders M, Basit A, et al. Preparation of personalized-dose salbutamol sulphate oral films with thermal Ink-Jet printing. Pharm Res. 2011;28(10):2386–2392.
  • Salmoria GV, Vieira FE, Muenz EA, et al. Additive manufacturing of PE/fluorouracil/progesterone intrauterine device for endometrial and ovarian cancer treatments. Polym Test. 2018;71:312–317.
  • D-G Y, Branford-White C, Yang Y-C, et al. A novel fast disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 2009;35(12):1530–1536.
  • Yu DG, Zhu L-M, Branford-White CJ, et al. Three-dimensional printing in pharmaceutics: promises and problems. J Pharm Sci. 2008;97(9):3666–3690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.